MHRA Drug Safety Update May 2017
Posted on:
MHRA Drug Safety Update May 2017
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (vol 10, issue 10, May 2017) has been published and includes articles on:
- Finasteride: rare reports of depression and suicidal thoughts;
- New e-learning modules on reporting suspected adverse drug reactions; and
- Letters sent to healthcare professionals in April 2017, including reminder of retigabine (Trobalt) withdrawal.